Calithera Biosciences, Inc. Quarterly General and Administrative Expense in USD from Q3 2013 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary: Calithera Biosciences, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q3 2013 to Q4 2022.
Calithera Biosciences, Inc. General and Administrative Expense for the quarter ending December 31, 2022 was $2.58M, a 43.8% decline year-over-year.
Calithera Biosciences, Inc. General and Administrative Expense for the twelve months ending December 31, 2022 was $13.5M, a 35.1% decline year-over-year.
Calithera Biosciences, Inc. annual General and Administrative Expense for 2022 was $13.5M, a 35.1% decline from 2021.
Calithera Biosciences, Inc. annual General and Administrative Expense for 2021 was $20.9M, a 2.36% increase from 2020.
Calithera Biosciences, Inc. annual General and Administrative Expense for 2020 was $20.4M, a 22.7% increase from 2019.

General and Administrative Expense, Trailing 12 Months (USD)

General and Administrative Expense, Quarterly (USD)

General and Administrative Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2022	$13.5M	$2.58M	-$2.01M	-43.8%	Oct 1, 2022	Dec 31, 2022	10-K	2023-03-31
Q3 2022	$15.6M	$3.08M	-$3.27M	-51.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$18.8M	$3.62M	-$869K	-19.4%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-16
Q1 2022	$19.7M	$4.26M	-$1.17M	-21.5%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$20.9M	$4.59M	-$992K	-17.8%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$21.8M	$6.34M	+$1.6M	+33.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$20.2M	$4.49M	-$609K	-12%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-16
Q1 2021	$20.9M	$5.43M	+$482K	+9.75%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$20.4M	$5.59M	+$1.04M	+22.7%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-31
Q3 2020	$19.3M	$4.74M	+$838K	+21.5%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020	$18.5M	$5.1M	+$1.11M	+27.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$17.4M	$4.95M	+$782K	+18.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$16.6M	$4.55M	+$1.3M	+40.2%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-31
Q3 2019	$15.3M	$3.91M	+$819K	+26.5%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$14.5M	$3.98M	+$486K	+13.9%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	$14M	$4.16M	+$656K	+18.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$13.3M	$3.25M	-$53K	-1.61%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-16
Q3 2018	$13.4M	$3.09M	+$13K	+0.42%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	$13.4M	$3.5M	+$650K	+22.8%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	$12.7M	$3.51M	+$200K	+6.05%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	$12.5M	$3.3M	+$289K	+9.6%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-11
Q3 2017	$12.2M	$3.07M	+$755K	+32.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07
Q2 2017	$11.5M	$2.85M	+$183K	+6.87%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-07
Q1 2017	$11.3M	$3.31M	+$717K	+27.7%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-10
Q4 2016	$10.6M	$3.01M	+$716K	+31.2%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-07
Q3 2016	$9.87M	$2.32M	+$121K	+5.51%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-02
Q2 2016	$9.75M	$2.67M	+$324K	+13.8%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-08
Q1 2016	$9.43M	$2.59M	+$354K	+15.8%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-09
Q4 2015	$9.07M	$2.3M	+$429K	+23%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-08
Q3 2015	$8.64M	$2.2M	+$851K	+63.2%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	$7.79M	$2.34M	+$1.03M	+78.8%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015	$6.76M	$2.24M	+$1.41M	+169%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-10
Q4 2014	$5.35M	$1.87M			Oct 1, 2014	Dec 31, 2014	10-K	2017-03-16
Q3 2014		$1.35M	+$764K	+131%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-09
Q2 2014		$1.31M			Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-10
Q1 2014		$832K			Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-11
Q3 2013		$583K			Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.